Dow Up 0.35% Nasdaq Down 0.02%

Hyperion Therapeutics, Inc. (HPTX)

-NasdaqGS
24.46 Down 0.68(2.70%) 4:00PM EDT
|After Hours : 24.46 0.00 (0.00%) 4:26PM EDT
Prev Close:25.14
Open:25.00
Bid:24.45 x 100
Ask:25.85 x 300
1y Target Est:39.40
Beta:1.811
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:24.42 - 25.07
52wk Range:18.97 - 32.98
Volume:74,063
Avg Vol (3m):133,592
Market Cap:503.80M
P/E (ttm):19.79
EPS (ttm):1.24
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for HPTX

Comparison

Symbol% ChgMkt Cap
HPTXDown 2.70%503.80M
ALXNDown 0.60%33.38B
CPIXUp 0.79%89.29M
SLXPDown 2.25%10.01B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):5.71
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.53
Quarterly EPS Est (Sep-14) :-0.12
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Hyperion Therapeutics, Inc., a commercial biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat disorders in the areas of orphan diseases and hepatology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback